These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27030674)

  • 21. Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor.
    Wong CH; Nguyen L; Peh J; Luu LM; Sanchez JS; Richardson SL; Tuccinardi T; Tsoi H; Chan WY; Chan HY; Baranger AM; Hergenrother PJ; Zimmerman SC
    J Am Chem Soc; 2014 Apr; 136(17):6355-61. PubMed ID: 24702247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Celf1 regulates cell cycle and is partially responsible for defective myoblast differentiation in myotonic dystrophy RNA toxicity.
    Peng X; Shen X; Chen X; Liang R; Azares AR; Liu Y
    Biochim Biophys Acta; 2015 Jul; 1852(7):1490-7. PubMed ID: 25887157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy.
    Li M; Zhuang Y; Batra R; Thomas JD; Li M; Nutter CA; Scotti MM; Carter HA; Wang ZJ; Huang XS; Pu CQ; Swanson MS; Xie W
    Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5472-5477. PubMed ID: 32086392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing.
    Paul S; Dansithong W; Kim D; Rossi J; Webster NJ; Comai L; Reddy S
    EMBO J; 2006 Sep; 25(18):4271-83. PubMed ID: 16946708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expanded CUG repeats Dysregulate RNA splicing by altering the stoichiometry of the muscleblind 1 complex.
    Paul S; Dansithong W; Jog SP; Holt I; Mittal S; Brook JD; Morris GE; Comai L; Reddy S
    J Biol Chem; 2011 Nov; 286(44):38427-38438. PubMed ID: 21900255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-322/-503 rescues myoblast defects in myotonic dystrophy type 1 cell model by targeting CUG repeats.
    Shen X; Xu F; Li M; Wu S; Zhang J; Wang A; Xu L; Liu Y; Zhu G
    Cell Death Dis; 2020 Oct; 11(10):891. PubMed ID: 33093470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytoplasmic and nuclear retained DMPK mRNAs are targets for RNA interference in myotonic dystrophy cells.
    Langlois MA; Boniface C; Wang G; Alluin J; Salvaterra PM; Puymirat J; Rossi JJ; Lee NS
    J Biol Chem; 2005 Apr; 280(17):16949-54. PubMed ID: 15722335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells.
    Loro E; Rinaldi F; Malena A; Masiero E; Novelli G; Angelini C; Romeo V; Sandri M; Botta A; Vergani L
    Cell Death Differ; 2010 Aug; 17(8):1315-24. PubMed ID: 20431600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel.
    Tang ZZ; Yarotskyy V; Wei L; Sobczak K; Nakamori M; Eichinger K; Moxley RT; Dirksen RT; Thornton CA
    Hum Mol Genet; 2012 Mar; 21(6):1312-24. PubMed ID: 22140091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenylbutazone induces expression of MBNL1 and suppresses formation of MBNL1-CUG RNA foci in a mouse model of myotonic dystrophy.
    Chen G; Masuda A; Konishi H; Ohkawara B; Ito M; Kinoshita M; Kiyama H; Matsuura T; Ohno K
    Sci Rep; 2016 Apr; 6():25317. PubMed ID: 27126921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms in DM1 - a focus on foci.
    Pettersson OJ; Aagaard L; Jensen TG; Damgaard CK
    Nucleic Acids Res; 2015 Feb; 43(4):2433-41. PubMed ID: 25605794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correction of Glycogen Synthase Kinase 3β in Myotonic Dystrophy 1 Reduces the Mutant RNA and Improves Postnatal Survival of DMSXL Mice.
    Wang M; Weng WC; Stock L; Lindquist D; Martinez A; Gourdon G; Timchenko N; Snape M; Timchenko L
    Mol Cell Biol; 2019 Nov; 39(21):. PubMed ID: 31383751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoplasmic reticulum stress in myotonic dystrophy type 1 muscle.
    Ikezoe K; Nakamori M; Furuya H; Arahata H; Kanemoto S; Kimura T; Imaizumi K; Takahashi MP; Sakoda S; Fujii N; Kira J
    Acta Neuropathol; 2007 Nov; 114(5):527-35. PubMed ID: 17661063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered signal transduction pathways and induction of autophagy in human myotonic dystrophy type 1 myoblasts.
    Beffy P; Del Carratore R; Masini M; Furling D; Puymirat J; Masiello P; Simili M
    Int J Biochem Cell Biol; 2010 Dec; 42(12):1973-83. PubMed ID: 20797447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcitriol increases MBNL1 expression and alleviates myotonic dystrophy phenotypes in HSA
    Huang K; Wang DD; Hu WB; Zeng WQ; Xu X; Li QX; Bi FF; Yang H; Qiu J
    J Transl Med; 2022 Dec; 20(1):588. PubMed ID: 36510245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discovery.
    Mondragon-Gonzalez R; Perlingeiro RCR
    Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29898953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy.
    Bisset DR; Stepniak-Konieczna EA; Zavaljevski M; Wei J; Carter GT; Weiss MD; Chamberlain JR
    Hum Mol Genet; 2015 Sep; 24(17):4971-83. PubMed ID: 26082468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing.
    Charlet-B N; Savkur RS; Singh G; Philips AV; Grice EA; Cooper TA
    Mol Cell; 2002 Jul; 10(1):45-53. PubMed ID: 12150906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ameliorated cellular hallmarks of myotonic dystrophy in hybrid myotubes from patient and unaffected donor cells.
    Raaijmakers RHL; Ausems CRM; Willemse M; Cumming SA; van Engelen BGM; Monckton DG; van Bokhoven H; Wansink DG
    Stem Cell Res Ther; 2024 Sep; 15(1):302. PubMed ID: 39278936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mir-206 partially rescues myogenesis deficiency by inhibiting CUGBP1 accumulation in the cell models of myotonic dystrophy.
    Dong W; Chen X; Wang M; Zheng Z; Zhang X; Xiao Q; Peng X
    Neurol Res; 2019 Jan; 41(1):9-18. PubMed ID: 30281408
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.